BTSG vs FMS
BrightSpring Health Services, Inc. and Fresenius Medical Care AG, side by side — 0 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | BTSG | FMS |
|---|---|---|
| Revenue | $12.9B | $14.6B |
| Net income | $190.7M | $1.1B |
| Gross margin | 11.8% | 32.4% |
| Net margin | 1.5% | 8.6% |
| Return on equity | 10.8% | 12.2% |
| Diluted EPS | $0.87 | $3.65 |
| Dividend / share | · | · |
| Payout ratio | · | 26.7% |
| Free cash flow | $394.7M | $1.3B |
| Equity | $1.9B | $9.2B |
| Net debt / equity | 1.29× | 0.78× |
| Current ratio | 1.57× | 1.77× |
| Revenue CAGR 5y | · | 6.6% |
| Profit CAGR 5y | · | 6.3% |
BTSG and FMS book revenue within 15% of each other, and FMS keeps more of each dollar of revenue as profit (8.6% against 1.5%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.